Metoprolol Succinate Extended-release (ER) Tablets are the generic version of AstraZeneca’s Toprol-XL Tablets, which are indicated for the treatment of hypertension.
The launch of the drug is believed to reflect Mylan’s continued commitment to bring difficult-to-formulate medicines to market.
According to IMS Health, Metoprolol Succinate ER Tablets generated sales of around $1.78bn for the 12 months ending 30 Sepember 2011, in the US.